In a trial of the MVA85A TB vaccine in infants, Fletcher and colleagues found a significant correlation between CMV IFN-γ ELISpot response at baseline and T-cell activation, in turn associated with future TB disease progression (18). The gene discussed is IFNG; the disease is tuberculosis.